With PQDT Open, you can read the full text of open access dissertations and theses free of charge.
About PQDT Open
Search
Depression is a debilitating and devastating mood disorder that can affect all ages and people of all races across all socioeconomic statuses. Conventional antidepressant medications only give one-third of relief from symptoms of depression, leaving the remainder to suffer from treatment-resistant depression (TRD). For the past two decades, researchers have looked into ketamine for the treatment of depression with promising results. All studies have validated that the intravenous (IV) use of ketamine is now the breakthrough treatment for TRD. This creates demand and a dire need to those are suffering from treatment-resistant depression. Ketafusion, LLC will specialize in delivery of safe and affordable intravenous ketamine infusion in the heart of Los Angeles County. It will provide personalized concierge care throughout every step of the treatment and recovery process to improve the quality of life of individuals battling TRD.
Some files may require a special program or browser plug-in. More Information
Advisor: | Gotz, Cindy |
Commitee: | Gerard, Nathan, Sinay, Tony |
School: | California State University, Long Beach |
Department: | Health Care Administration |
School Location: | United States -- California |
Source: | MAI 81/3(E), Masters Abstracts International |
Source Type: | DISSERTATION |
Subjects: | Health care management |
Keywords: | Mental depression, Medical treatment, Intravenous therapy |
Publication Number: | 13903920 |
ISBN: | 9781088322253 |